Old Web
English
Sign In
Acemap
>
authorDetail
>
David Bauché
David Bauché
Merck & Co.
Immunology
Innate lymphoid cell
Biology
Inflammatory bowel disease
Medicine
4
Papers
80
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions.
2020
Journal for ImmunoTherapy of Cancer
David Bauché
Smita Mauze
Christina Kochel
Jeff Grein
Anandi Sawant
Yulia Zybina
Wendy M. Blumenschein
Peng Yang
Lakshmanan Annamalai
Jennifer H. Yearley
Juha Punnonen
Edward P. Bowman
Alissa A. Chackerian
Drake LaFace
Show All
Source
Cite
Save
Citations (2)
IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis
2020
Science immunology
David Bauché
Barbara Joyce-Shaikh
Julie Fong
Alejandro V. Villarino
Karin S. Ku
Renu Jain
Yu-chi Lee
Lakshmanan Annamalai
Jennifer H. Yearley
Daniel J. Cua
Show All
Source
Cite
Save
Citations (14)
Induction and Analysis of Anti-CD40-induced Colitis in Mice
2019
Barbara Joyce-Shaikh
Daniel J. Cua
David Bauché
Show All
Source
Cite
Save
Citations (2)
LAG3+ Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1+ Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis
2018
Immunity
David Bauché
Barbara Joyce-Shaikh
Renu Jain
Jeff Grein
Karin S. Ku
Wendy M. Blumenschein
Stephanie C. Ganal-Vonarburg
Douglas C. Wilson
Terrill K. McClanahan
Rene de Waal Malefyt
Andrew J. Macpherson
Lakshmanan Annamalai
Jennifer H. Yearley
Daniel J. Cua
Show All
Source
Cite
Save
Citations (62)
1